BACKGROUND: Studies of family history of cancer and non-malignant diseases in childhood acute lymphoblastic leukemia (ALL) show inconsistent findings. Most studies show no increased risk with family history of cancer. Non-malignant diseases such as allergic diseases, autoimmune diseases, birth defects and thyroid diseases have been reported to be associated with ALL. METHODS: We conducted a case-control study of family history of cancer and selected non-malignant conditions (allergic diseases, autoimmune diseases, birth defects, and thyroid diseases). ALL cases were obtained from Children's Cancer Group institutions from January 1989 to June 1993. Controls were recruited via random digit dialing. Family history for first degree relatives and grandparents of ALL cases and controls was collected by structured telephone questionnaires. Conditional logistical regression was used to calculate odds ratios adjusting for potential confounders. RESULTS: We found a borderline association of ALL and having a family member with a history of cancer in cases (n=1842) compared to controls (n=1986) (OR=0.98, 95%CI=0.93, 1.00) and an inverse association for esophageal cancer based on small numbers. Family history of food and drug allergies demonstrated a modestly reduced risk (OR=0.83, 95%CI=0.73, 0.95) as did family history of rheumatoid arthritis (OR=0.79, 95%CI=0.65, 0.96). There were no associations with family history of any autoimmune diseases, immunodeficiencies, birth defects, thyroid diseases and risk of childhood ALL. CONCLUSIONS: These results show no association of overall family history of cancer with childhood ALL, while providing additional evidence for an inverse association with family history of allergic disease. Two potentially new associations of ALL with family history of esophageal cancer and rheumatoid arthritis require confirmation in other studies and validation with medical records.
BACKGROUND: Studies of family history of cancer and non-malignant diseases in childhood acute lymphoblastic leukemia (ALL) show inconsistent findings. Most studies show no increased risk with family history of cancer. Non-malignant diseases such as allergic diseases, autoimmune diseases, birth defects and thyroid diseases have been reported to be associated with ALL. METHODS: We conducted a case-control study of family history of cancer and selected non-malignant conditions (allergic diseases, autoimmune diseases, birth defects, and thyroid diseases). ALL cases were obtained from Children's Cancer Group institutions from January 1989 to June 1993. Controls were recruited via random digit dialing. Family history for first degree relatives and grandparents of ALL cases and controls was collected by structured telephone questionnaires. Conditional logistical regression was used to calculate odds ratios adjusting for potential confounders. RESULTS: We found a borderline association of ALL and having a family member with a history of cancer in cases (n=1842) compared to controls (n=1986) (OR=0.98, 95%CI=0.93, 1.00) and an inverse association for esophageal cancer based on small numbers. Family history of food and drug allergies demonstrated a modestly reduced risk (OR=0.83, 95%CI=0.73, 0.95) as did family history of rheumatoid arthritis (OR=0.79, 95%CI=0.65, 0.96). There were no associations with family history of any autoimmune diseases, immunodeficiencies, birth defects, thyroid diseases and risk of childhood ALL. CONCLUSIONS: These results show no association of overall family history of cancer with childhood ALL, while providing additional evidence for an inverse association with family history of allergic disease. Two potentially new associations of ALL with family history of esophageal cancer and rheumatoid arthritis require confirmation in other studies and validation with medical records.
Authors: Glinda S Cooper; Joan Wither; Tamara McKenzie; Jaime O Claudio; Sasha Bernatsky; Paul R Fortin Journal: J Rheumatol Date: 2008-09-01 Impact factor: 4.666
Authors: Debra L Friedman; Nina S Kadan-Lottick; John Whitton; Ann C Mertens; Yutaka Yasui; Yan Liu; Anna T Meadows; Leslie L Robison; Louise C Strong Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-08 Impact factor: 4.090
Authors: Jérémie Rudant; Tracy Lightfoot; Kevin Y Urayama; Eleni Petridou; John D Dockerty; Corrado Magnani; Elizabeth Milne; Logan G Spector; Lesley J Ashton; Nikolaos Dessypris; Alice Y Kang; Margaret Miller; Roberto Rondelli; Jill Simpson; Eftichia Stiakaki; Laurent Orsi; Eve Roman; Catherine Metayer; Claire Infante-Rivard; Jacqueline Clavel Journal: Am J Epidemiol Date: 2015-03-01 Impact factor: 4.897
Authors: Laura K Seppälä; Laura-Maria Madanat-Harjuoja; Rebecca Troisi; Joshua N Sampson; Maarit K Leinonen; Kim Vettenranta Journal: Acta Paediatr Date: 2021-03-08 Impact factor: 4.056
Authors: Catherine Metayer; Elizabeth Milne; Jacqueline Clavel; Claire Infante-Rivard; Eleni Petridou; Malcolm Taylor; Joachim Schüz; Logan G Spector; John D Dockerty; Corrado Magnani; Maria S Pombo-de-Oliveira; Daniel Sinnett; Michael Murphy; Eve Roman; Patricia Monge; Sameera Ezzat; Beth A Mueller; Michael E Scheurer; Bruce K Armstrong; Jill Birch; Peter Kaatsch; Sergio Koifman; Tracy Lightfoot; Parveen Bhatti; Melissa L Bondy; Jérémie Rudant; Kate O'Neill; Lucia Miligi; Nick Dessypris; Alice Y Kang; Patricia A Buffler Journal: Cancer Epidemiol Date: 2013-02-09 Impact factor: 2.984
Authors: M Forat-Yazdi; F Hosseini-Biouki; J Salehi; H Neamatzadeh; R Masoumi Dehshiri; Z Sadri; F Ghanizadeh; R Sheikhpour; H Zare-Zardini Journal: Iran J Ped Hematol Oncol Date: 2016-03-15